Article info
Recommendations
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
- Correspondence to Marlies C van der Goes, Department of Rheumatology and Clinical Immunology (F02.127), University Medical Center Utrecht, P O Box 85500, Utrecht 3508 GA, The Netherlands; m.c.vandergoes{at}umcutrecht.nl
Citation
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
Publication history
- Accepted March 9, 2010
- First published August 6, 2010.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Web Only Data
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions